HomeCompareLAAB vs JNJ

LAAB vs JNJ: Dividend Comparison 2026

LAAB yields 117.65% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LAAB wins by $7.80M in total portfolio value
10 years
LAAB
LAAB
● Live price
117.65%
Share price
$1.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.82M
Annual income
$2,925,300.61
Full LAAB calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LAAB vs JNJ

📍 LAAB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLAABJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LAAB + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LAAB pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LAAB
Annual income on $10K today (after 15% tax)
$10,000.00/yr
After 10yr DRIP, annual income (after tax)
$2,486,505.52/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LAAB beats the other by $2,485,801.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LAAB + JNJ for your $10,000?

LAAB: 50%JNJ: 50%
100% JNJ50/50100% LAAB
Portfolio after 10yr
$3.92M
Annual income
$1,463,064.19/yr
Blended yield
37.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LAAB
No analyst data
Altman Z
0.0
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LAAB buys
0
JNJ buys
0
No recent congressional trades found for LAAB or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLAABJNJ
Forward yield117.65%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$7.82M$20.0K
Annual income after 10y$2,925,300.61$827.78
Total dividends collected$7.09M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LAAB vs JNJ ($10,000, DRIP)

YearLAAB PortfolioLAAB Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$22,465$11,764.71$10,676$355.77+$11.8KLAAB
2$48,737$24,700.06$11,407$389.39+$37.3KLAAB
3$102,230$50,081.23$12,198$426.53+$90.0KLAAB
4$207,563$98,176.75$13,056$467.62+$194.5KLAAB
5$408,385$186,292.73$13,987$513.12+$394.4KLAAB
6$779,529$342,556.42$14,998$563.56+$764.5KLAAB
7$1,445,193$611,097.37$16,098$619.52+$1.43MLAAB
8$2,605,172$1,058,815.87$17,295$681.69+$2.59MLAAB
9$4,571,339$1,783,804.67$18,599$750.82+$4.55MLAAB
10$7,816,633$2,925,300.61$20,022$827.78+$7.80MLAAB

LAAB vs JNJ: Complete Analysis 2026

LAABStock

Startech Labs, Inc., through its subsidiaries, creates and develops utility/entertainment apps for Android and Apple's iOS platforms. The company develops customized web solutions for commercial and retail applications. It engages in the development of fare aggregators and travel metasearch engines. The company also owns and operates international online travel and hospitality web portals to search flights and hotels. It was formerly known as UpperSolution.com and changed its name to Startech Labs, Inc. on July 17, 2019. Startech Labs, Inc. was incorporated in 2013 and is based in New York, New York.

Full LAAB Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LAAB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LAAB vs SCHDLAAB vs JEPILAAB vs OLAAB vs KOLAAB vs MAINLAAB vs ABBVLAAB vs MRKLAAB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.